• "genOway is the Mercedes Benz of transgenic outsourcing companies."

    Prof. Robert TERKELTAUB

    Director at UC San Diego School of Medicine

    > read full testimonial
  • "We were highly impressed by the expert manner in which genOway’s scientists managed what I felt to be a rather..."

    Prof. Simon C. ROBSON

    Director at Beth Israel Deaconess Medical Center

    > read full testimonial
  • "We have worked with genOway in different projects for several years, and we are very impressed by their competence,..."

    Prof. Maria T. DIAZ-MECO

    Lab Head at Sanford Burnham Prebys Medical Discovery Institute

    > read full testimonial
  • "I am truly impressed with the responsiveness and help that I have obtained from genOway. It has been a pleasure to work..."

    Prof. Bellur S. PRABHAKAR

    Associate Dean at University of Illinois College of Medicine

    > read full testimonial
  • "Mouse knock-out technology is an important step in cancer research, it provides relevant answers to scientific questions..."

    Dr. Luisa LANFRANCONE

    IFOM-IEO Campus, University of Milan

    > read full testimonial
  • "genOway's technology is excellent and their mouse business is impressive. We are looking forward to working..."

    Dr. Ulrich THIBAUT

    Supervisory Board of Glycotope GmbH Berlin

    > read full testimonial
  • "Without you it would have been impossible for us to establish this transgenic mouse from the EUCOMM ES cells. I was most..."

    Dr. Matthias HUNDT

    Instructor at La Jolla Institute for Allergy & Immunology

    > read full testimonial
  • "It goes without saying that knockout technologies are an indispensible research tool in Hepatology. In this regard we..."

    Prof. Dr. Dieter HÄUSSINGER

    Director at Heinrich Heine University Düsseldorf

    > read full testimonial
  • "We are actively engaged in the production of a number of knock-in mouse models with genOway. We have been very pleased..."

    Prof. Stephen MOSS

    Chair of Biomedical Research at University College London

    > read full testimonial
  • "I have never witnessed such proactive behavior with customers. genOway truly understand our challenges and is equipped..."

    Dr. Carla BOCCACCIO

    University of Torino Medical School

    > read full testimonial
  • "genOway has carried out several projects for us. This collaboration has been very successful. Not just because we have..."

    Prof. Arne KLUNGLAND

    Lab Head at Oslo University Hospital

    > read full testimonial
  • "With the idea to develop a mouse model for the rare human disease ALD, we reached out to genOway to help us in finding..."

    Dr. Stephan KEMP

    Associate Professor at Academic Medical Center (AMC)

    > read full testimonial
  • "genOway has really impressed me with the quality of its service and its competence. I would emphasize their reliability..."

    Prof. Ruben PIO

    Director at CIMA, University of Navarra

    > read full testimonial
  • "Leader for the development of transgenic mice and rats, genOway is a very reliable biotechnology company. Their main..."

    Prof. Shomi BHATTACHARYA

    Director of Cabimer

    > read full testimonial
  • "genOway has already supplied us with several difficult-to-make knockout cell lines. We are impressed by the speed and..."

    Prof. Hans CLEVERS

    Director Research of Princess Maxima Center

    > read full testimonial
  • "genOway is a leading company in the field of genetically modified mouse and rat models. Its technology platform is..."

    Prof. Pier Paolo DI FIORE

    IFOM-IEO Campus, University of Milan

    > read full testimonial
  • "genOway has a professional attitude toward its customers. We had really appreciated their innovative technologies and..."

    Prof. Ivan DIKIC

    Director at Goethe University Frankfurt am Main

    > read full testimonial
  • "For more than two years we have worked with the scientific staff at genOway appreciating their fruitful and constant..."

    Prof. Gianfranco SEBASTIO

    University of Naples Federico II

    > read full testimonial
  • "genOway provides us with a very professional services within the expected timelines and high quality scientific..."

    Prof. Gerd WALZ

    Director at Albert Ludwigs University Freiburg

    > read full testimonial
  • "IEO and genOway collaboration started some years ago while we were looking for collaborative and highly professional..."

    Prof. Pier Giuseppe PELICCI

    Scientific Director of the European Institute of Oncology Milan

    > read full testimonial
More

At a Glance

At a Glance

genOway specializes in genetic designs to serve genetically modified mice, rat and cell lines of the highest standards for academic and bio-pharmaceutical researchers in:

28
countries worldwide
380
academic institutions
13
EU projects

170
Life Sciences
companies
17
of the Top 20
pharma

What We Stand For

What We Stand For

«Thorough project assessment, in-depth scientific analysis of your current and future needs, a unique technology portfolio, excellence in production, and dedicated customer care are the core pillars that distinguish our service. We translate your project into the most adapted and physiologically relevant research model.»

ALEXANDRE FRAICHARD,
Founder & GM

Immune Checkpoint Models

Immune Checkpoint Models

Humanized mouse models to assess the efficacy of immuno-oncology compounds

> Access the catalog
Immunodeficient Mouse Strains

Immunodeficient Mouse Strains

Most adapted mouse model to study and predict human immune responses in vivo

> Access the portfolio
Knockout Mouse Catalog

Knockout Mouse Catalog

Includes more than 2000 ready-to-use conditional Knockout and reporter mouse strains

> Find your ready-to-use model
Customized Rat Models

Customized Rat Models

Knockouts/Knockins in inbred and outbred strains, through advanced CRISPR technology

> Read on for more detail
Customized Mouse Models...

Customized Mouse Models...

Designed for high physiological relevancy and to specifically address your scientific questions

> Read on for more detail
Cell Line Engineering...

Cell Line Engineering...

Using CRISPR/Cas9 editing, our platform is fully adapted to modify your in-house cell line

> Read on for more detail

Latest Clients Publications

  • Chan S et al.

    Nat Cancer. 2022 Mar 7

    | An anti-PD-1-GITR-L bispecific agonist induces...

    Read
  • Zorn JA et al.

    Sci Rep. 2022 Mar 3

    | Humanization of a strategic CD3 epitope enables...

    Read
  • Poli V et al.

    Immunity. 2021 Dec 24

    | Inhibition of transcription factor NFAT activity...

    Read
  • Lassegue B et al.

    PLoS One. 2021 Dec 20

    | Characterization of Poldip2 knockout mice:...

    Read
  • Schmidt ERE et al.

    Nature. 2021 Nov

    | A human-specific modifier of cortical connectivity...

    Read